Transaction · 0001127602-25-007915

Malik Fady Ibraham

Malik Fady Ibraham, ER, reported an open-market or private sale at CYTOKINETICS INC involving 2000.000000 shares for an estimated $85000.00. Reported holdings after the transaction were 116071.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SER

CYTKCYTOKINETICS INC

Filing timeMar 04

Trade dateMar 04, 2025

Filing · SECView on SEC

InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows

Price at filing

—

Pre-filing

1mo ago1w ago1d ago

Returns since

7d30d90d180d1y

CYTK price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards

CYTK since 2025-03-04Filed 549 days ago · 30 days of pre-filing context shaded

Loading…

Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative

Type: Sell
Identifier: 0001127602-25-007915
Transaction date: Mar 04, 2025
Shares: 2.00k sh
Estimated value: -$8.50M
Holdings after: 116k sh

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M

Direct Ownership Repeat Seller

+10score

Filing-only score

+10

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP Research & Development

Officer YesDirector No10% NoOther No

Footnotes & amended

No footnotes recorded.

Original filing · 0001127602-25-007915

Related transactions

0 other filings

Same reporting owner

Recent company activity

0 recent txs

CYTK